Head-to-head · Cost-Efficiency Index
TeleCareSpot vs MaxLife
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
TeleCareSpot
Shoppers comparing headline monthly rates who are willing to call/email for the real dose-tier breakdown.
Visit TeleCareSpotMaxLife
Cost-first shoppers who want new patients specifically chasing the current limited-time promo, not for shoppers wanting stable published pricing.
Visit MaxLifeThe verdict
TeleCareSpot takes it, leading the Cost-Efficiency Index 59 to 58. TeleCareSpot is a telehealth weight-loss platform offering physician evaluations for compounded semaglutide, compounded tirzepatide, oral tirzepatide, and phentermine, with LegitScript verification displayed on-site. MaxLife still earns a C — Cost-first shoppers who want new patients specifically chasing the current limited-time promo, not for shoppers wanting stable published pricing.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs TeleCareSpot.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | TeleCareSpot | MaxLife |
|---|---|---|
| Cost-Efficiency Index | 59/100 | 58/100 |
| Semaglutide / mo | $299/mo (compounded) | $169/mo (compounded) |
| Tirzepatide / mo | $399/mo (compounded oral) | $169/mo (compounded) |
| Semaglutide / yr (modeled) | $3,588 | $2,028 |
| Tirzepatide / yr (modeled) | $4,788 | $2,028 |
| Coverage | 48 states | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #277 | #280 |
TeleCareSpot
59/100Where the value is
- LegitScript verification badge displayed on-site
- Offers both injectable and oral tirzepatide options
- Serves nearly all US states (only AK, MS, NJ excluded)
The tradeoffs
- 'From' pricing with no dose-tier breakdown -- real cost at your prescribed dose is unclear upfront
- No medical director named anywhere on the site
MaxLife
58/100Where the value is
- Low advertised entry price ($169) plus a free first week for new clients
- Clear phone and email contact information for direct follow-up
- Simple, straightforward homepage messaging
The tradeoffs
- Headline price is explicitly a rotating seasonal promo ('March special'), not a stable rate
- No ongoing/renewal price disclosed anywhere after the promo period
Regulatory note: the FDA issued a warning letter to MaxLife Technologies Inc. dba Maxlife in February 2026. We still list and link to MaxLife; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.